Evidence map›Paper›PMID 38069159›Full record

ArticleInternational journal of molecular sciences2023

Sodium-Doped 3-Amino-4-hydroxybenzoic Acid: Rediscovered Matrix for Direct MALDI Glycotyping of

Shogo Urakami, Hiroshi Hinou

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. MALDI O-antigen glycotyping ofBBA advances · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shogo UrakamiGraduate School of Life Science, Hokkaido University, Sapporo 001-0021, Japan.ORCID 0000-0002-4066-5360
Hiroshi HinouFrontier Research Center for Advanced Material and Life Science, Faculty of Advanced Life Science, Hokkaido University, Sapporo 001-0021, Japan.ORCID 0000-0003-2223-7300
Hokkaido University · JP

Funding

Japan Society for the Promotion of Science 22H02191Japan Society for the Promotion of Science 23KJ0052
6 · The paper itself

Abstract

3-Amino-4-hydroxybenzoic acid (AHB) was the first matrix identified by glycoprotein glycan analysis using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). However, compared to commonly used matrices, such as 2,5-dihydroxybenzoic acid (DHB), AHB is less efficient at glycan ionization and lacks the ability to ionize other molecular species, such as peptides, and thus is no longer used. In this study, we focused on the glycan-selective ionization ability of AHB and its low-noise properties in the low-molecular-weight region, as we expected that these properties could be enhanced by adding sodium to AHB. Sodium-doped AHB (AHB/Na) selectively imparts sodium adduct ions onto

Indexed as

GlycopeptidesMucinsAminobenzoatesGlycoproteinsHydroxybenzoatesPolysaccharidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTandem Mass Spectrometry3-amino-4-hydroxybenzoic acid3-hydroxybenzoic acidAminobenzoatesGlycopeptidesGlycoproteinsHydroxybenzoatesMucinsPolysaccharides3-amino-4-hydroxybenzoic acidglycotypingMALDImucinO-glycan

Identifiers

PMID38069159
PMCPMC10706304
OpenAlexW4389088390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.